reported that MTFR2 can promote lung adenocarcinoma cell proliferation and metastasis through the AKT pathway, and it can be used as a prognostic biomarker for lung adenocarcinoma patients (12). The gene discussed is AKT1; the disease is lung adenocarcinoma.